Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
12 evidence topics · 6 sources
Anaphylm (dibutepinephrine)
Type I allergic reactions including anaphylaxis
- Manufacturer
- Aquestive Therapeutics
- Regulatory submission
- NDA resubmitted September 2026
- Launch
- Not announced
- Last updated